Comerica Securities’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $409K | Sell |
6,043
-264
| -4% | -$17.9K | 0.03% | 307 |
|
|
2023
Q2 | $451K | Sell |
6,307
-418
| -6% | -$29.9K | 0.03% | 314 |
|
|
2023
Q1 | $467K | Buy |
6,725
+1,049
| +18% | +$72.8K | 0.03% | 307 |
|
|
2022
Q4 | $385K | Buy |
5,676
+276
| +5% | +$18.7K | 0.03% | 340 |
|
|
2022
Q3 | $296K | Buy |
5,400
+1,638
| +44% | +$89.8K | 0.02% | 347 |
|
|
2022
Q2 | $249K | Sell |
3,762
-1,791
| -32% | -$119K | 0.02% | 408 |
|
|
2022
Q1 | $368K | Sell |
5,553
-233
| -4% | -$15.4K | 0.02% | 366 |
|
|
2021
Q4 | $337K | Buy |
5,786
+233
| +4% | +$13.6K | 0.02% | 397 |
|
|
2021
Q3 | $334K | Sell |
5,553
-116
| -2% | -$6.98K | 0.02% | 386 |
|
|
2021
Q2 | $340K | Sell |
5,669
-566
| -9% | -$33.9K | 0.03% | 380 |
|
|
2021
Q1 | $310K | Buy |
+6,235
| New | +$310K | 0.02% | 403 |
|
|
2020
Q4 | – | Sell |
-5,089
| Closed | -$279K | – | 479 |
|
|
2020
Q3 | $279K | Sell |
5,089
-266
| -5% | -$14.6K | 0.02% | 355 |
|
|
2020
Q2 | $283K | Sell |
5,355
-294
| -5% | -$15.5K | 0.03% | 349 |
|
|
2020
Q1 | $252K | Sell |
5,649
-1,421
| -20% | -$63.4K | 0.03% | 344 |
|
|
2019
Q4 | $353K | Sell |
7,070
-192
| -3% | -$9.59K | 0.03% | 331 |
|
|
2019
Q3 | $324K | Buy |
7,262
+1,158
| +19% | +$51.7K | 0.03% | 333 |
|
|
2019
Q2 | $252K | Buy |
6,104
+577
| +10% | +$23.8K | 0.03% | 370 |
|
|
2019
Q1 | $223K | Sell |
5,527
-2,087
| -27% | -$84.2K | 0.03% | 392 |
|
|
2018
Q4 | $289K | Sell |
7,614
-1,953
| -20% | -$74.1K | 0.04% | 322 |
|
|
2018
Q3 | $379K | Sell |
9,567
-5,524
| -37% | -$219K | 0.04% | 316 |
|
|
2018
Q2 | $530K | Sell |
15,091
-1,181
| -7% | -$41.5K | 0.06% | 261 |
|
|
2018
Q1 | $569K | Sell |
16,272
-2,581
| -14% | -$90.3K | 0.07% | 251 |
|
|
2017
Q4 | $654K | Buy |
18,853
+1,547
| +9% | +$53.7K | 0.08% | 239 |
|
|
2017
Q3 | $586K | Buy |
17,306
+2,937
| +20% | +$99.5K | 0.08% | 235 |
|
|
2017
Q2 | $490K | Buy |
14,369
+2,681
| +23% | +$91.4K | 0.07% | 253 |
|
|
2017
Q1 | $364K | Buy |
+11,688
| New | +$364K | 0.06% | 287 |
|
|
2016
Q4 | – | Sell |
-6,293
| Closed | -$207K | – | 236 |
|
|
2016
Q3 | $207K | Buy |
+6,293
| New | +$207K | 0.09% | 202 |
|